Circulating Biomarkers in Elderly Patients with Heart Failure: A Real-Life Study
Authors:
- Velia CassanoVCVelia Cassano
- Caterina GabrieleCGCaterina Gabriele
- Maria Rosangela ScarcelliMSMaria Rosangela Scarcelli
- Giuseppe ArmentaroGAGiuseppe Armentaro
- Giandomenico SeveriniGSGiandomenico Severini
- Domenico MartireDMDomenico Martire
- Carlo Alberto PasturaCPCarlo Alberto Pastura
- Sofia MiceliSMSofia Miceli
- Marta Letizia HribalMHMarta Letizia Hribal
- Giuseppe Massimo Claudio RosanoGRGiuseppe Massimo Claudio Rosano
- Marco GaspariMarco Gaspari
- Angela SciacquaAngela Sciacqua
Open Access
- 28 February 2026
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 15 (3) , 305
Abstract
Background: Heart failure (HF) is a clinical syndrome that involves multiple interconnected pathways. Circulating biomarkers in HF emerged as powerful tools for risk stratification, diagnostic confirmation, prognostic assessment, and monitoring of treatment efficacy. The aim of the present study was to evaluate circulating levels of biomarkers in elderly patients with improved HF ejection fraction, previously with left ventricular ejection fraction (LVEF) p < 0.001). Proteomic analysis revealed selective changes in key cardiovascular (CV)-related proteins, such as insulin-like growth factor-binding protein 4 (IBP4), thrombospondin-4 (TSP4), intercellular adhesion molecule 1 (ICAM1), and syndecan-4 (SDC4). Conclusions: This study demonstrates significant improvements across multiple CV biomarkers after six months of therapy optimisation in HFimpEF patients, providing evidence for comprehensive therapeutic effects targeting inflammation, oxidative stress, neurohormonal activation, and thrombotic risk.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart FailureJAMA Cardiology, 2025
- Heart Failure Improvement, Remission, and Recovery: A European Journal of Heart Failure Expert Consensus DocumentEuropean Journal of Heart Failure, 2025
- Biomarkers for the diagnosis and management of heart failureHeart Failure Reviews, 2021
- Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureEuropean Journal of Heart Failure, 2021
- Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future DirectionsAmerican Journal of Cardiovascular Drugs, 2020
- Biomarkers in heart failure: the past, current and futureHeart Failure Reviews, 2019
- BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic reviewHeart Failure Reviews, 2014
- Thrombospondins in the heart: potential functions in cardiac remodelingJournal of Cell Communication and Signaling, 2009
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986